E. Ohman J or Asset Management AB Sells 2,468 Shares of Stryker Corporation $SYK

E. Ohman J or Asset Management AB lessened its position in shares of Stryker Corporation (NYSE:SYK) by 16.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,186 shares of the medical technology company’s stock after selling 2,468 shares during the quarter. E. Ohman J or Asset Management AB’s holdings in Stryker were worth $4,283,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Davis R M Inc. lifted its stake in Stryker by 1.8% during the third quarter. Davis R M Inc. now owns 138,732 shares of the medical technology company’s stock worth $51,285,000 after purchasing an additional 2,512 shares during the period. Terra Alpha Investments LLC bought a new stake in shares of Stryker in the 3rd quarter valued at approximately $1,216,000. Kepler Cheuvreux Suisse SA acquired a new position in shares of Stryker in the 3rd quarter worth approximately $27,952,000. Diversified Trust Co lifted its position in shares of Stryker by 45.6% during the 3rd quarter. Diversified Trust Co now owns 12,445 shares of the medical technology company’s stock worth $4,601,000 after buying an additional 3,899 shares during the period. Finally, SVB Wealth LLC bought a new position in shares of Stryker during the 2nd quarter worth approximately $4,785,000. 77.09% of the stock is currently owned by institutional investors.

Stryker Price Performance

Stryker stock opened at $332.48 on Tuesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.21 and a current ratio of 1.89. The firm has a market cap of $127.24 billion, a P/E ratio of 39.58, a P/E/G ratio of 1.96 and a beta of 0.85. The business’s fifty day moving average is $362.68 and its two-hundred day moving average is $365.29. Stryker Corporation has a 52 week low of $328.23 and a 52 week high of $404.87.

Stryker (NYSE:SYK) last announced its earnings results on Thursday, January 29th. The medical technology company reported $4.47 earnings per share for the quarter, beating analysts’ consensus estimates of $4.40 by $0.07. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The company had revenue of $7.17 billion during the quarter, compared to analyst estimates of $7.12 billion. During the same period last year, the company posted $4.01 earnings per share. The firm’s quarterly revenue was up 11.4% compared to the same quarter last year. Equities research analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be given a $0.88 dividend. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date is Tuesday, March 31st. Stryker’s dividend payout ratio (DPR) is presently 41.90%.

Key Stories Impacting Stryker

Here are the key news stories impacting Stryker this week:

• Positive Sentiment: Company statement that the cybersecurity incident has been contained and reported remediation is underway, reducing immediate operational disruption risk. Stryker Addresses and Contains Recent Cybersecurity Incident
• Positive Sentiment: Company reports progress in restoration efforts and that operations are stabilizing — supports expectations for limited revenue disruption if recovery continues. Stryker reports progress in restoration efforts after cyberattack, operations continue to stabilize
• Neutral Sentiment: Market coverage and peer comparisons may reframe investor valuation assumptions (Envista and Intuitive Surgical comparisons highlight relative growth and margin dynamics). NVST or SYK: Which Is the Better Value Stock Right Now? Intuitive Surgical vs. Stryker: Which Surgical Tech Stock Leads?
• Neutral Sentiment: Corporate housekeeping: Stryker announced its 2026 Annual Meeting of Shareholders — routine but relevant for governance-minded investors. Stryker announces Annual Meeting of Shareholders
• Negative Sentiment: Independent reporting warns attackers — including state-linked groups — are increasingly targeting enterprise systems to disrupt operations and extract leverage; this elevates the potential for future incidents, regulatory scrutiny, and remediation costs. Stryker Cyberattack Highlights Criminal Focus on Enterprise Systems

Insider Buying and Selling at Stryker

In other Stryker news, Director Ronda E. Stryker sold 250,000 shares of the business’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total value of $90,730,000.00. Following the completion of the transaction, the director directly owned 2,457,331 shares of the company’s stock, valued at approximately $891,814,566.52. The trade was a 9.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 5.20% of the company’s stock.

Analyst Ratings Changes

A number of analysts have weighed in on SYK shares. Evercore set a $390.00 price target on Stryker in a research report on Monday, January 5th. Truist Financial reduced their target price on shares of Stryker from $400.00 to $392.00 and set a “hold” rating on the stock in a research note on Thursday, December 18th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Stryker in a report on Monday, December 22nd. Jefferies Financial Group reiterated a “buy” rating and set a $465.00 target price on shares of Stryker in a research report on Wednesday, March 4th. Finally, Barclays restated an “overweight” rating and issued a $469.00 price target on shares of Stryker in a research report on Monday, February 2nd. Fourteen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Stryker currently has an average rating of “Moderate Buy” and a consensus price target of $427.50.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.